Variables | Time | Group 1 Placebo group (n = 42) | Group 2 Omega 3 group (n = 42) | Group 3 Vitamin D group (n = 42) | Group 4 Vitamin + Omega 3 group (n = 42) |
---|---|---|---|---|---|
Vitamin D | Before | 25.47 (5.83) | 23.56 (6.42) | 21.43 (8) | 22.03 (6.92) |
After | 20.97 (6.63) | 21.17 (7.40) | 29.71 (12.11) | 31.71 (11.51) | |
P-value¶ | < .001* | < .001* | < .001* | < .001* | |
FBS (mg/dL) | Before | 104.52 (6.39) | 103.87 (5.88) | 103.74 (5.11) | 103.71 (4.73) |
After | 107.12 (9.94) | 97.23 (5.87) | 100.18 (8.94) | 94.33 (8.02) | |
P-value¶ | < .001* | < .001* | < .001* | < .001* | |
Insulin (µIU/mL) | Before | 7.36 (4.12) | 9.14 (3.14) | 7.73 (3.66) | 10.35 (3.13) |
After | 10.42 (4.89) | 7.34 (3.53) | 9.65 (4.08) | 7.73 (2.4) | |
P-value¶ | < .001* | < .001* | < .001* | < .001* | |
HOMA-IR | Before | 1.91 (1.13) | 2.34 (0.82) | 1.98 (0.94) | 2.65 (0.83) |
After | 2.75 (1.34) | 1.75 (0.78) | 2.38 (1.07) | 1.79 (0.6) | |
P-value¶ | < .001* | < .001* | < .001* | < .001* | |
HOMA-B | Before | 0.64 (0.34) | 0.82 (0.56) | 0.69 (0.33) | 0.95 (0.42) |
After | 0.92 (0.64) | 0.81 (0.29) | 0.96 (0.4) | 0.92 (0.28) | |
P-value¶ | < .001* | .92 | < .001* | 0.04* |